Label-free single-molecule digital Raman assay for quantification of low abundance biomarkers (DigiRaman)

An analysis of combined data from genomics, transcriptomics, and proteomics provides in-depth understanding of cellular pathways and open up new potentials in biomarker discovery, drug discovery and personalized medicine. However, the fact that proteins cannot be amplified results in a serious lag of proteomics behind genomics and transcriptomics.

Project information

Project duration


Project funder

Biocenter Oulu

Project coordinator

University of Oulu

Contact information

Project leader

Project description

Current protein analysis and sequencing relies mainly on mass spectroscopy that generally requires 1 million copies of proteins. The low sensitivity of mass spectroscopy faces a significant challenge in analyzing trace amount of biomarkers in human biofluids in early stage of diseases and the small amount of low-abundance proteins in single cells. This DigiRaman project aims to develop a novel single-molecule digital Raman assay to first identify and then quantify low-abundance biomarkers. Based on our plasmonic nanogap biosensor, the project will be conducted by integrating single-particle manipulation technique, nanogap-enhanced Raman spectroscopy, active feedback control with machine learning analysis. The technology developed by this project can be the key technologies for single-cell proteomics and diagnostic devices for early diagnosis of diseases.